Agenus Net Worth
Agenus Net Worth Breakdown | AGEN |
Agenus Net Worth Analysis
Agenus' net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Agenus' financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Agenus' overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Agenus' net worth analysis. One common approach is to calculate Agenus' market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Agenus' stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Agenus' net worth. This approach calculates the present value of Agenus' future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Agenus' cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Agenus' net worth. This involves comparing Agenus' financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Agenus' net worth relative to its peers.
Enterprise Value |
|
To determine if Agenus is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Agenus' net worth research are outlined below:
| Agenus Inc generated a negative expected return over the last 90 days | |
| Agenus Inc has high historical volatility and very poor performance | |
| Agenus Inc has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 156.31 M. Net Loss for the year was (245.76 M) with loss before overhead, payroll, taxes, and interest of (28.68 M). | |
| Agenus Inc currently holds about 218.23 M in cash with (224.2 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.72. | |
| Agenus Inc has a frail financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: Agenus to Participate in B. Riley Securities Precision Oncology Radiopharma Investor Conference |
Agenus Quarterly Good Will |
|
Agenus uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Agenus Inc. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Agenus' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 12th of March 2024 Upcoming Quarterly Report | View | |
| 14th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 12th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Agenus Target Price Consensus
Agenus target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Agenus' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 5 | Buy |
Most Agenus analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Agenus stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Agenus Inc, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationAgenus Target Price Projection
Agenus' current and average target prices are 3.12 and 8.00, respectively. The current price of Agenus is the price at which Agenus Inc is currently trading. On the other hand, Agenus' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Target Price
Analyst Consensus On Agenus Target Price
Know Agenus' Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Agenus is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Agenus Inc backward and forwards among themselves. Agenus' institutional investor refers to the entity that pools money to purchase Agenus' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Bank Of America Corp | 2024-12-31 | 107.1 K | Jane Street Group Llc | 2024-12-31 | 105.7 K | Fmr Inc | 2024-12-31 | 91.6 K | Key Client Fiduciary Advisors, Llc | 2024-12-31 | 68.1 K | Deutsche Bank Ag | 2024-12-31 | 61.1 K | Simplex Trading, Llc | 2024-09-30 | 57.2 K | Bank Of New York Mellon Corp | 2024-12-31 | 54.7 K | Charles Schwab Investment Management Inc | 2024-12-31 | 48 K | Avestar Capital, Llc | 2024-12-31 | 41.5 K | Vanguard Group Inc | 2024-12-31 | 2.4 M | Blackrock Inc | 2024-12-31 | 1.6 M |
Follow Agenus' market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 72.96 M.Market Cap |
|
Project Agenus' profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.99) | (1.04) | |
| Return On Capital Employed | (3.16) | (3.00) | |
| Return On Assets | (0.90) | (0.95) | |
| Return On Equity | 1.38 | 1.45 |
When accessing Agenus' net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Agenus' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Agenus' profitability and make more informed investment decisions.
Evaluate Agenus' management efficiency
Agenus Inc has return on total asset (ROA) of (0.2195) % which means that it has lost $0.2195 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (12.7883) %, meaning that it created substantial loss on money invested by shareholders. Agenus' management efficiency ratios could be used to measure how well Agenus manages its routine affairs as well as how well it operates its assets and liabilities. As of the 26th of February 2025, Return On Equity is likely to grow to 1.45, while Return On Tangible Assets are likely to drop (1.04). At this time, Agenus' Debt To Assets are very stable compared to the past year. As of the 26th of February 2025, Asset Turnover is likely to grow to 0.47, while Non Currrent Assets Other are likely to drop about 3.5 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | (9.54) | (9.06) | |
| Tangible Book Value Per Share | (11.41) | (10.84) | |
| Enterprise Value Over EBITDA | (1.84) | (1.93) | |
| Price Book Value Ratio | (2.13) | (2.02) | |
| Enterprise Value Multiple | (1.84) | (1.93) | |
| Price Fair Value | (2.13) | (2.02) | |
| Enterprise Value | 579 M | 550 M |
Agenus Inc benefits from a proactive management team that anticipates market trends. Our analysis delves into how this proactive stance influences financial metrics and stock valuation.
Enterprise Value Revenue 0.6738 | Revenue | Quarterly Revenue Growth 0.033 | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Agenus insiders, such as employees or executives, is commonly permitted as long as it does not rely on Agenus' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Agenus insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Agenus Corporate Filings
F4 | 25th of February 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 10th of February 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
13A | 8th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
Agenus Earnings Estimation Breakdown
The calculation of Agenus' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Agenus is estimated to be -3.0045 with the future projection ranging from a low of -3.625 to a high of -2.605. Please be aware that this consensus of annual earnings estimates for Agenus Inc is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-3.62 Lowest | Expected EPS | -2.6 Highest |
Agenus Earnings Projection Consensus
Suppose the current estimates of Agenus' value are higher than the current market price of the Agenus stock. In this case, investors may conclude that Agenus is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Agenus' stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2024 | Current EPS (TTM) | |
| 5 | 79.84% | -3.08 | -3.0045 | -11.02 |
Agenus Earnings per Share Projection vs Actual
Actual Earning per Share of Agenus refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Agenus Inc predict the company's earnings will be in the future. The higher the earnings per share of Agenus, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Agenus Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Agenus, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Agenus should always be considered in relation to other companies to make a more educated investment decision.Agenus Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Agenus' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-11-05 | 2024-09-30 | -2.33 | -3.08 | -0.75 | 32 | ||
2024-08-08 | 2024-06-30 | -1.44 | -2.52 | -1.08 | 75 | ||
2024-05-07 | 2024-03-31 | -3.22 | -3.04 | 0.18 | 5 | ||
2024-03-14 | 2023-12-31 | -0.05 | -0.13 | -0.08 | 160 | ||
2023-11-07 | 2023-09-30 | -0.19 | -0.16 | 0.03 | 15 | ||
2023-08-08 | 2023-06-30 | -0.2 | -0.2 | 0.0 | 0 | ||
2023-05-09 | 2023-03-31 | -0.21 | -0.22 | -0.01 | 4 | ||
2023-03-14 | 2022-12-31 | -0.22 | -0.24 | -0.02 | 9 | ||
2022-11-08 | 2022-09-30 | -0.19 | -0.19 | 0.0 | 0 | ||
2022-08-09 | 2022-06-30 | -0.23 | -0.17 | 0.06 | 26 | ||
2022-05-10 | 2022-03-31 | -0.3 | -0.19 | 0.11 | 36 | ||
2022-03-01 | 2021-12-31 | -0.16 | -0.26 | -0.1 | 62 | ||
2021-11-09 | 2021-09-30 | 0.46 | 0.69 | 0.23 | 50 | ||
2021-08-09 | 2021-06-30 | -0.24 | -0.37 | -0.13 | 54 | ||
2021-05-06 | 2021-03-31 | -0.31 | -0.27 | 0.04 | 12 | ||
2021-03-15 | 2020-12-31 | -0.22 | -0.2 | 0.02 | 9 | ||
2020-10-29 | 2020-09-30 | -0.26 | -0.28 | -0.02 | 7 | ||
2020-08-06 | 2020-06-30 | -0.27 | -0.28 | -0.01 | 3 | ||
2020-05-07 | 2020-03-31 | -0.33 | -0.31 | 0.02 | 6 | ||
2020-03-12 | 2019-12-31 | -0.38 | -0.22 | 0.16 | 42 | ||
2019-11-04 | 2019-09-30 | -0.38 | -0.33 | 0.05 | 13 | ||
2019-08-08 | 2019-06-30 | -0.33 | -0.38 | -0.05 | 15 | ||
2019-05-09 | 2019-03-31 | -0.29 | 0.12 | 0.41 | 141 | ||
2019-03-14 | 2018-12-31 | -0.28 | -0.4 | -0.12 | 42 | ||
2018-11-06 | 2018-09-30 | -0.25 | -0.29 | -0.04 | 16 | ||
2018-08-09 | 2018-06-30 | -0.4 | -0.24 | 0.16 | 40 | ||
2018-05-07 | 2018-03-31 | -0.3 | -0.42 | -0.12 | 40 | ||
2018-03-15 | 2017-12-31 | -0.29 | -0.35 | -0.06 | 20 | ||
2017-11-07 | 2017-09-30 | -0.34 | -0.37 | -0.03 | 8 | ||
2017-08-03 | 2017-06-30 | -0.37 | -0.32 | 0.05 | 13 | ||
2017-05-04 | 2017-03-31 | -0.27 | -0.18 | 0.09 | 33 | ||
2017-03-09 | 2016-12-31 | -0.3 | -0.3 | 0.0 | 0 | ||
2016-10-27 | 2016-09-30 | -0.3 | -0.47 | -0.17 | 56 | ||
2016-07-28 | 2016-06-30 | -0.34 | -0.33 | 0.01 | 2 | ||
2016-04-28 | 2016-03-31 | -0.22 | -0.37 | -0.15 | 68 | ||
2016-03-03 | 2015-12-31 | -0.17 | -0.18 | -0.01 | 5 | ||
2015-10-27 | 2015-09-30 | -0.16 | -0.16 | 0.0 | 0 | ||
2015-07-23 | 2015-06-30 | -0.15 | -0.53 | -0.38 | 253 | ||
2015-04-23 | 2015-03-31 | -0.01 | -0.28 | -0.27 | 2700 | ||
2015-02-26 | 2014-12-31 | -0.16 | -0.41 | -0.25 | 156 | ||
2014-10-31 | 2014-09-30 | -0.15 | -0.13 | 0.02 | 13 | ||
2014-07-24 | 2014-06-30 | -0.16 | -0.12 | 0.04 | 25 | ||
2014-05-08 | 2014-03-31 | -0.13 | -0.01 | 0.12 | 92 | ||
2014-03-05 | 2013-12-31 | -0.24 | -0.16 | 0.08 | 33 | ||
2013-10-24 | 2013-09-30 | -0.26 | -0.24 | 0.02 | 7 | ||
2013-07-25 | 2013-06-30 | -0.22 | -0.4 | -0.18 | 81 | ||
2013-04-24 | 2013-03-31 | -0.22 | -0.35 | -0.13 | 59 | ||
2013-02-28 | 2012-12-31 | -0.24 | -0.23 | 0.01 | 4 | ||
2012-10-25 | 2012-09-30 | -0.29 | -0.24 | 0.05 | 17 | ||
2012-08-02 | 2012-06-30 | -0.27 | -0.31 | -0.04 | 14 | ||
2012-04-25 | 2012-03-31 | -0.28 | 0.29 | 0.57 | 203 | ||
2012-03-05 | 2011-12-31 | -0.28 | -0.29 | -0.01 | 3 | ||
2011-10-27 | 2011-09-30 | -0.28 | -0.28 | 0.0 | 0 | ||
2011-07-28 | 2011-06-30 | -0.3 | -0.3 | 0.0 | 0 | ||
2011-04-28 | 2011-03-31 | -0.24 | -0.3 | -0.06 | 25 | ||
2011-02-17 | 2010-12-31 | -0.3 | -0.18 | 0.12 | 40 | ||
2010-10-28 | 2010-09-30 | -0.36 | -0.36 | 0.0 | 0 | ||
2010-07-29 | 2010-06-30 | -0.3 | -0.3 | 0.0 | 0 | ||
2010-04-29 | 2010-03-31 | -0.36 | -0.6 | -0.24 | 66 | ||
2010-02-18 | 2009-12-31 | -0.54 | 0.12 | 0.66 | 122 | ||
2009-10-29 | 2009-09-30 | -0.66 | -0.78 | -0.12 | 18 | ||
2009-05-07 | 2009-03-31 | -0.72 | -0.84 | -0.12 | 16 | ||
2009-02-19 | 2008-12-31 | -0.96 | 0.48 | 1.44 | 150 | ||
2008-11-05 | 2008-09-30 | -1.08 | -1.02 | 0.06 | 5 | ||
2008-07-31 | 2008-06-30 | -1.08 | -1.14 | -0.06 | 5 | ||
2008-05-01 | 2008-03-31 | -0.84 | -1.2 | -0.36 | 42 | ||
2008-02-21 | 2007-12-31 | -1.38 | -0.96 | 0.42 | 30 | ||
2007-11-01 | 2007-09-30 | -1.38 | -1.5 | -0.12 | 8 | ||
2007-08-02 | 2007-06-30 | -1.32 | -1.32 | 0.0 | 0 | ||
2007-02-21 | 2006-12-31 | -1.26 | -1.56 | -0.3 | 23 | ||
2006-10-31 | 2006-09-30 | -1.34 | -1.44 | -0.1 | 7 | ||
2006-08-01 | 2006-06-30 | -1.42 | -1.86 | -0.44 | 30 | ||
2006-05-03 | 2006-03-31 | -2.1 | -2.16 | -0.06 | 2 | ||
2006-02-23 | 2005-12-31 | -2.58 | -2.34 | 0.24 | 9 | ||
2005-10-27 | 2005-09-30 | -2.58 | -2.28 | 0.3 | 11 | ||
2005-07-28 | 2005-06-30 | -2.44 | -2.82 | -0.38 | 15 | ||
2005-05-05 | 2005-03-31 | -2.35 | -2.4 | -0.05 | 2 | ||
2005-02-24 | 2004-12-31 | -2.4 | -2.28 | 0.12 | 5 | ||
2004-10-19 | 2004-09-30 | -2.59 | -2.46 | 0.13 | 5 | ||
2004-07-22 | 2004-06-30 | -2.02 | -0.42 | 1.6 | 79 | ||
2004-04-20 | 2004-03-31 | -2.48 | -2.46 | 0.02 | 0 | ||
2004-02-19 | 2003-12-31 | -2.59 | -2.76 | -0.17 | 6 | ||
2003-10-23 | 2003-09-30 | -2.43 | -2.7 | -0.27 | 11 | ||
2003-07-23 | 2003-06-30 | -2.4 | -2.52 | -0.12 | 5 | ||
2003-04-16 | 2003-03-31 | -2.82 | -2.16 | 0.66 | 23 | ||
2003-02-19 | 2002-12-31 | -2.59 | -2.94 | -0.35 | 13 | ||
2002-10-23 | 2002-09-30 | -2.42 | -2.4 | 0.02 | 0 | ||
2002-07-25 | 2002-06-30 | -2.3 | -2.4 | -0.1 | 4 | ||
2002-04-23 | 2002-03-31 | -2.22 | -2.22 | 0.0 | 0 | ||
2002-02-20 | 2001-12-31 | -2.34 | -2.4 | -0.06 | 2 | ||
2001-10-23 | 2001-09-30 | -1.92 | -2.4 | -0.48 | 25 | ||
2001-07-24 | 2001-06-30 | -1.71 | -1.86 | -0.15 | 8 | ||
2001-04-24 | 2001-03-31 | -1.62 | -1.62 | 0.0 | 0 | ||
2001-02-21 | 2000-12-31 | -1.62 | -3.72 | -2.1 | 129 | ||
2000-10-26 | 2000-09-30 | -1.32 | -1.14 | 0.18 | 13 | ||
2000-07-25 | 2000-06-30 | -1.11 | -1.2 | -0.09 | 8 | ||
2000-04-24 | 2000-03-31 | -1.08 | -1.14 | -0.06 | 5 |
Agenus Corporate Management
| Julie DeSander | Chief Officer | Profile | |
| Alfred Dadson | Chief Officer | Profile | |
| Eric Humes | Chief Officer | Profile | |
| Regina Grebla | VP Communications | Profile | |
| Dr MBA | Chief Officer | Profile | |
| John Castle | Head Bioinformatics | Profile | |
| Zack Armen | Head Development | Profile |
Already Invested in Agenus Inc?
The danger of trading Agenus Inc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Agenus is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Agenus. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Agenus Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Agenus Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Agenus' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Agenus Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Agenus Inc Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Agenus Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agenus. If investors know Agenus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agenus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (11.02) | Revenue Per Share | Quarterly Revenue Growth 0.033 | Return On Assets | Return On Equity |
The market value of Agenus Inc is measured differently than its book value, which is the value of Agenus that is recorded on the company's balance sheet. Investors also form their own opinion of Agenus' value that differs from its market value or its book value, called intrinsic value, which is Agenus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agenus' market value can be influenced by many factors that don't directly affect Agenus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agenus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Agenus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agenus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.